📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transient Inhibition of PI3Kd Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus. (2020)

First Author: Ferguson MS

Attributed to: Development of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2020.02.017

PubMed Identifier: 32145202

Publication URI: http://europepmc.org/abstract/MED/32145202

Type: Journal Article/Review

Volume: 28

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 5

ISSN: 1525-0016